Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver cancer: Approaching a personalized care
Jordi Bruix, Kwang–Hyub Han, Gregory J. Gores, et al.
Journal of Hepatology (2015) Vol. 62, Iss. 1, pp. S144-S156
Open Access | Times Cited: 267

Showing 1-25 of 267 citing articles:

Hepatocellular carcinoma
Josep M. Llovet, Jessica Zucman‐Rossi, Eli Pikarsky, et al.
Nature Reviews Disease Primers (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 2110
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Jordi Bruix, María Reig, Morris Sherman
Gastroenterology (2016) Vol. 150, Iss. 4, pp. 835-853
Open Access | Times Cited: 1571
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix, Tadatoshi Takayama, Vincenzo Mazzaferro, et al.
The Lancet Oncology (2015) Vol. 16, Iss. 13, pp. 1344-1354
Closed Access | Times Cited: 978
The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
Galina Khemlina, Sadakatsu Ikeda, Razelle Kurzrock
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 404
Functional and genetic deconstruction of the cellular origin in liver cancer
Jens U. Marquardt, Jesper B. Andersen, Snorri S. Thorgeirsson
Nature reviews. Cancer (2015) Vol. 15, Iss. 11, pp. 653-667
Closed Access | Times Cited: 290
The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma
Jinlan Huang, Shunwang Cao, Qishui Ou, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 185
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
Yu Wang, Baocheng Deng
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 629-652
Closed Access | Times Cited: 156
Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions
Marc Hilmi, Cindy Neuzillet, Julien Caldéraro, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 147
Genetic alterations in hepatocellular carcinoma: An update
Zhao-Shan Niu, Xiao-Jun Niu, Wenhong Wang
World Journal of Gastroenterology (2016) Vol. 22, Iss. 41, pp. 9069-9069
Open Access | Times Cited: 153
CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study
Jiliang Qiu, Baogang Peng, Yunqiang Tang, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 7, pp. 734-742
Closed Access | Times Cited: 149
Personalized treatment of patients with very early hepatocellular carcinoma
Alessandro Vitale, Markus Peck‐Radosavljevic, Edoardo G. Giannini, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 2, pp. 412-423
Open Access | Times Cited: 146
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
Germana Castelli, Elvira Pelosi, Ugo Testa
Cancers (2017) Vol. 9, Iss. 9, pp. 127-127
Open Access | Times Cited: 144
Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes
Lulu Sun, Yuqing Wang, Jin Cen, et al.
Nature Cell Biology (2019) Vol. 21, Iss. 8, pp. 1015-1026
Closed Access | Times Cited: 132
Wnt/β-Catenin Signaling in Liver Cancers
Wenhui Wang, Ron Smits, Haiping Hao, et al.
Cancers (2019) Vol. 11, Iss. 7, pp. 926-926
Open Access | Times Cited: 130
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis
Atsushi Hiraoka, Takashi Kumada, Masatoshi Kudo, et al.
Digestive Diseases (2017) Vol. 35, Iss. 6, pp. 602-610
Closed Access | Times Cited: 125
Hepatocellular carcinoma: Where are we?
Roberto Mazzanti
World Journal of Experimental Medicine (2016) Vol. 6, Iss. 1, pp. 21-21
Open Access | Times Cited: 123
Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma
Wei Guo, Yun‐Fan Sun, Min-Na Shen, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 9, pp. 2203-2213
Open Access | Times Cited: 123
Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy
Yuee Cai, Yingqi Xu, Hon Fai Chan, et al.
Molecular Pharmaceutics (2016) Vol. 13, Iss. 3, pp. 699-709
Closed Access | Times Cited: 122
Treatment of Metastatic Lymph Nodes in the Neck from Papillary Thyroid Carcinoma with Percutaneous Laser Ablation
Giovanni Mauri, Luca Cova, Tiziana Ierace, et al.
CardioVascular and Interventional Radiology (2016) Vol. 39, Iss. 7, pp. 1023-1030
Closed Access | Times Cited: 112
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
Sheng‐Nan Lu, Jing‐Houng Wang, Chien‐Wei Su, et al.
Journal of the Formosan Medical Association (2017) Vol. 117, Iss. 5, pp. 381-403
Open Access | Times Cited: 111
Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
Feihu Xie, Lejia Sun, Yuan Pang, et al.
Biomaterials (2020) Vol. 265, pp. 120416-120416
Closed Access | Times Cited: 107
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE
Isabel Schobert, Lynn Jeanette Savic, Julius Chapiro, et al.
European Radiology (2020) Vol. 30, Iss. 10, pp. 5663-5673
Open Access | Times Cited: 98
Treatment of Hepatocellular Carcinoma
Álvaro Díaz‐González, María Reig, Jordi Bruix
Digestive Diseases (2016) Vol. 34, Iss. 5, pp. 597-602
Closed Access | Times Cited: 97
Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta‐analysis
Benjamin Menahem, Jean Lubrano, Christophe Duvoux, et al.
Liver Transplantation (2017) Vol. 23, Iss. 6, pp. 836-844
Open Access | Times Cited: 97
Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country
Nathalie Goutté, Philippe Sogni, Noelle Bendersky, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 3, pp. 537-544
Open Access | Times Cited: 92
Page 1 - Next Page

Scroll to top